PT Kalbe Farma Tbk. Income Statement

Financials in millions IDR. Fiscal year is January - December.

Millions IDR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	36,214,715	35,324,544	32,627,776	30,449,134	28,933,503	26,261,195
Revenue Growth (YoY)	9.57%	8.27%	7.16%	5.24%	10.18%	13.62%
Cost of Revenue	22,333,565	21,531,187	19,904,640	18,897,645	17,414,902	15,156,133
Gross Profit	13,881,150	13,793,357	12,723,136	11,551,489	11,518,601	11,105,061
Selling, General & Admin	8,840,547	8,690,279	8,091,947	7,591,031	7,008,307	6,800,994
Research & Development	506,016	499,711	471,600	322,297	286,805	285,159
Other Operating Expenses	24,298	24,483	58,243	-11,322	-24,730	-11,954
Operating Expenses	9,370,861	9,214,473	8,621,790	7,902,006	7,270,382	7,074,199
Operating Income	4,510,289	4,578,884	4,101,346	3,649,483	4,248,219	4,030,862
Interest Expense	-30,462	-35,247	-56,319	-82,958	-41,226	-45,486
Interest & Investment Income	160,826	179,197	179,101	88,218	81,827	110,792
Earnings From Equity Investments	72,986	68,193	28,288	26,972	36,498	80,070
Currency Exchange Gain (Loss)	-34,845	-34,845	22,025	-55,928	155,833	-20,022
Other Non Operating Income (Expenses)	-15,547	-15,547	-12,915	-12,146	-13,833	-11,898
EBT Excluding Unusual Items	4,663,247	4,740,635	4,261,526	3,613,641	4,467,318	4,144,318
Gain (Loss) on Sale of Investments	-	-	-	15,850	12,105	20,305
Gain (Loss) on Sale of Assets	71,707	71,707	-8,751	1,093	3,038	7,782
Pretax Income	4,734,954	4,812,342	4,252,775	3,630,584	4,482,461	4,172,405
Income Tax Expense	1,048,358	1,067,967	1,006,205	852,179	1,032,378	940,397
Earnings From Continuing Operations	3,686,596	3,744,375	3,246,570	2,778,405	3,450,083	3,232,008
Minority Interest in Earnings	-69,444	-79,377	-5,933	-11,657	-67,874	-48,386
Net Income	3,617,152	3,664,998	3,240,637	2,766,748	3,382,210	3,183,621
Net Income to Common	3,617,152	3,664,998	3,240,637	2,766,748	3,382,210	3,183,621
Net Income Growth	7.66%	13.10%	17.13%	-18.20%	6.24%	16.48%
Shares Outstanding (Basic)	45,415	45,524	46,187	46,256	46,516	46,873
Shares Outstanding (Diluted)	45,415	45,524	46,187	46,256	46,516	46,873
Shares Change (YoY)	-1.36%	-1.43%	-0.15%	-0.56%	-0.76%	-0.00%
EPS (Basic)	79.65	80.51	70.16	59.81	72.71	67.92
EPS (Diluted)	79.65	80.51	70.16	59.81	72.71	67.92
EPS Growth	9.15%	14.74%	17.30%	-17.74%	7.05%	16.48%
Free Cash Flow	2,452,293	2,544,854	3,877,270	2,026,545	566,431	2,322,036
Free Cash Flow Per Share	54.00	55.90	83.95	43.81	12.18	49.54
Dividend Per Share	-	-	36.000	31.000	38.000	35.000
Dividend Growth	-	-	16.13%	-18.42%	8.57%	25.00%
Gross Margin	38.33%	39.05%	39.00%	37.94%	39.81%	42.29%
Operating Margin	12.45%	12.96%	12.57%	11.99%	14.68%	15.35%
Profit Margin	9.99%	10.38%	9.93%	9.09%	11.69%	12.12%
Free Cash Flow Margin	6.77%	7.20%	11.88%	6.66%	1.96%	8.84%
EBITDA	5,286,784	5,346,191	4,817,446	4,314,625	4,907,579	4,649,287
EBITDA Margin	14.60%	15.13%	14.77%	14.17%	16.96%	17.70%
D&A For EBITDA	776,495	767,307	716,100	665,142	659,360	618,424
EBIT	4,510,289	4,578,884	4,101,346	3,649,483	4,248,219	4,030,862
EBIT Margin	12.45%	12.96%	12.57%	11.99%	14.68%	15.35%
Effective Tax Rate	22.14%	22.19%	23.66%	23.47%	23.03%	22.54%
Advertising Expenses	-	2,881,667	2,307,240	2,133,714	2,062,426	1,999,089

Source: S&P Global Market Intelligence. Standard template. Financial Sources.